Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Kringle Pharma, Oct-Jun (Cumulative 3Q) Net Income Loss Widens, Apr-Jun Net Income Loss Widens
4884 Kringle Pharma,Inc. 【J-GAAP】
Earnings ReportKringle Pharma,Inc. <4884> [TSE Growth] announced its financial results after the market closed on August 8th (15:40). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending September 2025 (October 2024 to June 2025) expanded to a loss of 739 million yen (compared to a loss of 518 million yen in the same period last year).
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the July to September period (4Q) is expected to further decrease loss of 207 million yen (compared to a loss of 238 million yen in the same period last year).
In the most recent three-month period, from April to June (3Q), the net loss expanded to a loss of 227 million yen (compared to a loss of 152 million yen in the same period last year). The operating profit/loss margin drastically worsened from -1183.3% in the same period last year to -1261.1%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Jun, 2022 | 51 | -620 | -577 | -578 | -107.5 | ー | Aug 14, 2023 | J-GAAP |
| Oct - Jun, 2023 | 61 | -579 | -517 | -518 | -82.8 | ー | Aug 9, 2024 | J-GAAP |
| Oct - Jun, 2024 | 53 | -738 | -738 | -739 | -108.4 | ー | Aug 8, 2025 | J-GAAP |
| YoY | -13.1% | -27.5% | -42.7% | -42.7% | -30.9% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 37 | -451 | -389 | -390 | -61.0 | 0 | Nov 13, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 36 | -428 | -434 | -434 | -62.0 | 0 | Jul 16, 2025 | J-GAAP |
| YoY | -2.7% | +5.1% | -11.6% | -11.3% | -1.7% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2023 | 69 | -888 | -852 | -854 | -158.5 | 0 | Nov 13, 2023 | J-GAAP |
| Sep, 2024 | 80 | -817 | -754 | -756 | -118.2 | 0 | Nov 13, 2024 | J-GAAP |
| Sep, 2025 Guidance | 71 | -939 | -945 | -946 | -135.2 | 0 | Jul 16, 2025 | J-GAAP |
| YoY | -11.3% | -14.9% | -25.3% | -25.1% | -14.3% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2024 | 18 | -213 | -152 | -152 | -24.3 | -1,183.3 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 19 | -238 | -237 | -238 | -37.2 | -1,252.6 | Nov 13, 2024 | J-GAAP |
| Oct - Dec, 2024 | 18 | -212 | -212 | -212 | -31.2 | -1,177.8 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 17 | -299 | -299 | -300 | -44.0 | -1,758.8 | May 12, 2025 | J-GAAP |
| Apr - Jun, 2025 | 18 | -227 | -227 | -227 | -33.3 | -1,261.1 | Aug 8, 2025 | J-GAAP |
| YoY | 0.0% | -6.6% | -49.3% | -49.3% | -37.1% |
Related Articles
KOBAYASHI YOKO, Apr-Jun (1Q) Ordinary Profit Decreases by 18%
TOYO DRILUBE, 16% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 4 Yen
HOSHIIRYO-SANKI, Apr-Jun (1Q) Ordinary Profit Increases by 24%
Naigai Tec, Apr-Jun (1Q) Ordinary Profit Decreases by 59%
IMV, Oct-Jun (Cumulative 3Q) Ordinary Profit Increases by 13%
Japan Ecosystem, Oct-Jun (Cumulative 3Q) Ordinary Profit Decreases by 34%, Apr-Jun Ordinary Profit Turns to Loss
FUJICOPIAN, Apr-Jun (2Q) Ordinary Profit Decreases by 55%
IC, Oct-Jun (Cumulative 3Q) Ordinary Profit Decreases by 1%, Exceeds Full-Year Plan
HAVIX, Apr-Jun (1Q) Ordinary Profit Decreases by 81%
SCINEX, Apr-Jun (1Q) Ordinary Profit Turns to Loss